InvestorsHub Logo
Followers 828
Posts 119581
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 1039

Monday, 01/10/2022 11:31:02 AM

Monday, January 10, 2022 11:31:02 AM

Post# of 1162
BMY issues 2022 non-GAAP EPS guidance of $7.65-7.95—starts $15M share-repurchase program with $5M ASR in 1Q22:

https://finance.yahoo.com/news/bristol-myers-squibb-highlight-long-114500205.html

Today, the Company also announced that it plans to execute an accelerated share repurchase (ASR) agreement during the first quarter of 2022 to repurchase up to $5 billion of Bristol Myers Squibb common stock. The ASR is part of the Company’s previously disclosed multi-year $15 billion share repurchase authorization.

JPM CC slides:
https://www.sec.gov/Archives/edgar/data/0000014272/000114036122001018/brhc10032672_ex99-1.htm

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News